118 results on '"Wallace, Joseph M."'
Search Results
2. Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD)
3. Compromised femoral and lumbovertebral bone in the Dp(16)1Yey Down syndrome mouse model
4. Effects of novel raloxifene analogs alone or in combination with mechanical loading in the Col1a2G610c/+ murine model of osteogenesis imperfecta
5. Practical Considerations for the Design, Execution, and Interpretation of Studies Involving Whole-Bone Bending Tests of Rodent Bones
6. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms
7. Correlation analysis of cartilage wear with biochemical composition, viscoelastic properties and friction
8. Skeletal Hard Tissue Biomechanics
9. List of Contributors
10. Fragile X Messenger Ribonucleoprotein 1 (FMR1), a novel inhibitor of osteoblast/osteocyte differentiation, regulates bone formation, mass, and strength in young and aged male and female mice
11. NMP4, an Arbiter of Bone Cell Secretory Capacity and Regulator of Skeletal Response to PTH Therapy
12. Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease
13. Genetic dissection of triplicated chromosome 21 orthologs yields varying skeletal traits in Down syndrome model mice
14. Synthesis Studies and the Evaluation of C6 Raloxifene Derivatives
15. The Kk/Ay Mouse is a Model of Obese Type 2 Diabetes with Compromised Skeletal Properties
16. Skeletal Impacts of Dual In Vivo Compressive Axial Tibial and Ulnar Loading in Mice
17. Calcitonin and Raloxifene Each Improve Mechanical Properties of Diseased Bone Through Non-Cell Mediated Mechanisms
18. A novel murine model of combined insulin-dependent diabetes and chronic kidney disease has greater skeletal detriments than either disease individually
19. Skeletal manifestations in a streptozotocin-induced C57BL/6 model of Type 1 diabetes
20. Combined Thermoneutral Housing and Raloxifene Treatment Improves Trabecular Bone Microarchitecture and Strength in Growing Female Mice
21. Raloxifene Stimulates Estrogen Signaling to Protect Against Age- and Sex-Related Intervertebral Disc Degeneration in Mice
22. High glucose-induced inhibition of osteoblast like MC3T3-E1 differentiation promotes mitochondrial perturbations
23. Dietary supplements do not improve bone morphology or mechanical properties in young female C57BL/6 mice
24. Calcimimetics Alter Periosteal and Perilacunar Bone Matrix Composition and Material Properties in Early Chronic Kidney Disease
25. Bone hydration: How we can evaluate it, what can it tell us, and is it an effective therapeutic target?
26. Segregating the effects of ferric citrate‐mediated iron utilization and FGF23 in a mouse model of CKD
27. Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease
28. Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models
29. Non‐Additive Effects of Combined NOX1 /4 Inhibition and Calcimimetic Treatment on a Rat Model of Chronic Kidney Disease‐Mineral and Bone Disorder ( CKD‐MBD )
30. A Novel Murine Model of Combined Type 1 Diabetes and Chronic Kidney Disease Has Greater Skeletal Detriments than Either Disease Individually
31. Skeletal Manifestations in a Streptozotocin-Induced Murine Model of Diabetes
32. The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype
33. Iron deficiency and high-intensity running interval training do not impact femoral or tibial bone in young female rats
34. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts
35. MicroRNAs and osteocytes
36. List of Contributors
37. Skeletal Hard Tissue Biomechanics
38. Morphological and mechanical characterization of bone phenotypes in the Amish G610C murine model of osteogenesis imperfecta
39. Nmp4, a Regulator of Induced Osteoanabolism, Also Influences Insulin Secretion and Sensitivity
40. Raloxifene reduces sex- and age-related intervertebral disc degeneration in mice by estrogen signaling
41. Limited impacts of thermoneutral housing on bone morphology and mechanical properties in growing female mice exposed to external loading and raloxifene treatment
42. The impact of advanced glycation end products on bone properties in chronic kidney disease
43. The Effect of Single Versus Group μCT on the Detection of Trabecular and Cortical Disease Phenotypes in Mouse Bones
44. Control of Bone Matrix Properties by Osteocytes
45. Effects of Raloxifene and tibial loading on bone mass and mechanics in male and female mice
46. Mechanical suppression of breast cancer cell invasion and paracrine signaling to osteoclasts requires nucleo-cytoskeletal connectivity
47. The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure
48. Interaction of sexual dimorphism and gene dosage imbalance in skeletal deficits associated with Down syndrome
49. Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice
50. 6′-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.